Catalog classification, reference sizes, lab math links, and source-backed data. Educational use only — not medical advice.
Researched for: P21 evidence and protocol review
Also known as: P021, P21 peptide
P21 is a peptide derived from p21 (Cip1/Waf1), a cyclin-dependent kinase inhibitor protein, studied in rodent models for effects on neuroinflammation, synaptic plasticity, and cognitive function. In aged Fischer rats, P21 counteracted age-related declines in learning and memory, reportedly by restoring hippocampal and cortical neurogenesis and upregulating brain-derived neurotrophic factor (BDNF) signaling. Separate preclinical work in 3xTg-AD transgenic mice found P21 attenuated tau and, to a lesser extent, amyloid-beta pathology, with effects proposed to act through the BDNF/TrkB/PI3-K/AKT/GSK3-beta pathway. All available evidence is preclinical (rodent); no human clinical trials have been published, and mechanistic details (specific receptor targets, optimal dosing, exposure route) remain incompletely characterized.
Catalog descriptions reflect research context only. Not a medical claim or treatment recommendation.
Data source: Primary literature, regulator records, trial registries, and identity-specific evidence search
Reflects preclinical/research literature context only. Not a medical claim, dosing instruction, or treatment recommendation.
The catalog name P21 is often used for P021, the CNTF-derived peptidergic compound Ac-DGGL(A)G-NH2. All located dosing evidence is preclinical and oral-in-feed; no human or injectable protocol was found.
Supplementary research context only. Not medical advice or a treatment recommendation.
Found a relevant Reddit or forum thread about this compound? Suggest it below. Every suggestion is reviewed by an editor before it appears -- nothing is published automatically.
Published articles on this site that mention P21 or one of its catalog aliases.
Research Use Only. All content is for educational and research reference only. Not medical advice, a treatment recommendation, or guidance on human use. Compounds are not FDA-approved drugs unless specifically noted.